CSIR-Centre for Cellular Molecular Biology(CSIR-CCMB), Hyderabad
Combating Coronovirus Outbreak - CSIR Steps up to its Scientific Social Responsibility

With Covid-19, the new deadly strain of Coronavirus, affecting almost 4 lakh and causing the death of more than 17,000 people in 193 countries, the Council of Scientific and Industrial Research (CSIR) has stepped in with its expertise in various areas.

CSIR Intensifies Fight Against COVID-19, Rolls Out Key Initiatives to Combat Coronavirus Spread

With the coronavirus pandemic continuing its deadly run by infecting more than a million people and causing the death of more than 82,000 people across the world, the laboratories of the Council of Scientific and Industrial Research (CSIR) intensified their efforts at combating the pandemic.

#CSIRFightsCovid19 – A Snapshot

Surveillance at the level of the virus, humans, and geographical origins and distributions is a critical step in combating Covid-19.

#CSIRFightsCovid19

Ever since the Coronavirus pandemic broke out, CSIR has mounted a strategic, well-coordinated and integrated approach towards mitigating the Coronavirus outbreak.

CSIR Combating Coronavirus

CSIR has been leading the fight against COVID-19 and contributing extensively to overcome the deadly coronavirus outbreak.

CSIR to Conduct Study on Transmission of SARS-CoV-2 Virus

CSIR has announced it will conduct a study to ascertain the possibility of the spread of the virus through the air. 

CSIR-CCMB and Aurobindo Pharma to Collaborate on Developing Vaccine

CSIR-CCMB and Aurobindo Pharma Ltd have entered into a collaboration for developing a COVID-19 vaccine against SARS-CoV-2.

CSIR Labs Detect Presence of SARS-CoV-2 in Sewage Samples of Hyderabad

In a collaborative effort, CSIR-CCMB & CSIR-IICT processed sewage samples from major sewage treatment plants (STPs) in Hyderabad to detect the presence of SARS-CoV-2 viral RNA.

CSIR-CLRI Provides Training to Chennai Hospital Staff

Ten doctors and technicians from the ESI Medical College and Hospital, Chennai, were provided training in COVID 19 diagnosis.

CSIR scientists find viral strain circulating in India has 70% similarity with major strain around the world

CSIR-CCMB scientists have found that the clade that is now dominant in India is A2a, which has a similarity with 70% of genomes studied worldwide.

CSIR-CCMB and Apollo Hospitals Announce Successful Collaboration for Development of Rapid, Safe and Cost-effective COVID-19 Testing Kits

CSIR-CCMB and the Apollo Hospitals Enterprise Ltd. on 10 December 2020 announced a collaboration for joint manufacturing and commercialisation of an innovative dry swab test, Direct Amplification rapid RT-PCR (DArRT-PCR) for SARS-CoV-2 detection.